Curaleaf Holdings, Inc. (CURLF)
CURLF is quoted over the counter, not listed on an exchange. Curaleaf Holdings, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | CURLF, quoted over the counter |
| SEC CIK | 0001756770 |
| OTC Markets tier | OTCQX (price source, 2026-11-13) |
| SEC industry code | Medicinal Chemicals & Botanical Products |
| Business address | Stamford, CT |
| Incorporated in | BC |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-03 |
| Cash and burn | $92.4M cash; operating cash flow $37.3M a quarter. | Report 2026-09-30 |
| Shares outstanding | 264,996,138 (2026-10-27). | Cover page 2026-10-27 |
| Reverse splits, 3 years | 1; latest 1-for-3 on 2026-06-05 | Source 2026-06-05 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PKF O'Connor Davies, LLP, New York, New York, United States | PCAOB Form AP 2026-08-24 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $352.6M | -$32.7M | $21.1M | $92.4M | $629.5M | Needs four quarters | 10-Q 2026-11-03 |
| Q2 2026 2026-06-30 | $340.1M | $12.5M | Not filed | $94.6M | $611.5M | Needs four quarters | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | Not filed | $69.8M | Not filed | Not filed | No debt tags | Needs four quarters | 10-Q 2026-11-03 |
| Q4 2025 2025-12-31 | $333.1M | -$59.8M | $43.0M | $89.2M | $548.7M | $1.3B | 40-F 2026-02-27 |
| Q3 2025 2025-09-30 | $317.9M | -$57.0M | $47.7M | $92.8M | No debt tags | Needs four quarters | 10-Q 2026-11-03 |
| Q2 2025 2025-06-30 | $310.6M | -$53.2M | Not filed | $87.7M | No debt tags | Needs four quarters | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | Not filed | -$61.1M | Not filed | Not filed | No debt tags | Needs four quarters | 10-Q 2026-08-06 |
| Q1 2020 2020-03-31 | Not filed | -$35.3M | Not filed | Not filed | No debt tags | Needs four quarters | 40-F 2021-04-29 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 40-F | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-11-03 |
| Latest current report | 8-K | 2026-11-10 |
Source: SEC EDGAR submissions feed, 230 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier